We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran-coated charcoal method were 3, 3, 4, and 5 fmol/mg, respectively. Our data indicate that the incidence of melanoma with detectable ER is low, which suggests that any potential clinical usefulness of the ER assay in melanoma might be limited.
No takes yet. Share an insight, caveat, or question.
Creagan et al. (1980) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: